St. Jude Medical Inc. has agreed to pay up to $14.25 million to settle about 950 claims from patients that their Riata defibrillator leads were prematurely degrading.
St. Jude, a global heart-device maker based in Little Canada, pulled its Riata and Riata ST silicone-only leads off the market in 2010 after reports of defects surfaced. More than 227,000 Riata leads had been distributed worldwide at the time, though many were removed in follow-up surgeries.
Leads are thin wires that carry electric shocks from an implanted defibrillator to restore normal heart rhythm.
Help employers find you! Check out all the jobs and post your resume.
